Brolucizumab Shows Promising Outcomes for Diabetic Macular Edema Care Jacinthlyn Sylvia3 Dec 2023 6:00 PM ISTAn update of a 52-week clinical trial unveiled promising results of brolucizumab compared to the standard aflibercept in enhancing diabetic macular...
Brolucizumab as good as aflibercept for improving clinical outcomes in Diabetic Macular Edema Outcomes: JAMA Jacinthlyn Sylvia19 Nov 2023 5:00 PM ISTA recent 52-week phase 3 clinical trial published in the Journal of American Medical Association compared the efficacy and safety of brolucizumab...
Brolucizumab treatment associated with visual acuity improvement for neovascular age-related macular degeneration Dr Ishan Kataria8 Oct 2023 8:00 PM ISTBrolucizumab is a low molecular weight humanized antibody fragment as a vascular endothelial growth factor (VEGF) inhibitor. Registered Phase III...
Brolucizumab shows robust visual gains and anatomical improvements in patients with DME: AJO Dr Ishan Kataria26 Dec 2022 8:00 PM ISTDiabetic macular edema (DME) is a common microvascularcomplication in patients with diabetes, and has become the leading cause ofvision loss in the...
CDSCO tells Sandoz to review and report PSUR data of Brolucizumab injection Dr. Divya Colin27 Nov 2022 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has recommended the drug maker...
CSTTA may prevent brolucizumab related intraocular inflammation in nAMD Dr. Shravani Dali16 Sept 2022 8:00 PM ISTConcomitant use of sub-tenon's capsule triamcinolone acetonide with brolucizumab may prevent intraocular inflammation according to a recent study...
Brolucizumab improves visual outcomes in diabetic macular edema patients Medical Dialogues Editorial Team14 Feb 2022 9:00 AM ISTUSA: In patients with diabetic macular edema (DME), brolucizumab 6mg exhibited significant visual and anatomical improvements, as well as a favorable...
Brolucizumab efficacious and safe in Neovascular Age-Related Macular Degeneration: BRAILLE Study Dr Ishan Kataria14 Oct 2021 9:00 AM ISTAge-related macular degeneration (AMD) is a chronic, progressive disease of the central retina and a major cause of irreversible vision loss...
"Brolucizumab - alterative for neovascular Age-related macular degeneration?", SHIFT study aswers Dr Ishan Kataria13 May 2021 6:45 PM ISTAge-related macular degeneration (AMD) is the leading cause of blindness in the elderly in industrialised countries. With the advent of ...
Ophthalmology Highlights of 2020 Dr Sudha Seetharam28 Dec 2020 5:15 PM ISTThe year 2020 has turned out to be completely different from what anyone could have imagined it to be because of the COVID-19 pandemic that has...
